GB1042531A - Therapeutic composition - Google Patents
Therapeutic compositionInfo
- Publication number
- GB1042531A GB1042531A GB924/64A GB92464A GB1042531A GB 1042531 A GB1042531 A GB 1042531A GB 924/64 A GB924/64 A GB 924/64A GB 92464 A GB92464 A GB 92464A GB 1042531 A GB1042531 A GB 1042531A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dithiocarboxy
- ornithine
- bis
- taurine
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention comprises the pharmaceutically acceptable salts of N-dithiocarboxy-taurine and N,N1 - bis(dithiocarboxy) - ornithine. In examples the disodium salt of N-dithiocarboxy-taurine is prepared by mixing taurine with sodium hydroxide and adding carbon disulphide thereto, and the trisodium salt of L-N,N1-bis (dithiocarboxy)-ornithine is prepared by adding carbon disulphide to a mixture of L-ornithine and sodium hydroxide.ALSO:The invention comprises a composition for the prevention or treatment of liver disease and ammonia or heavy metal intoxication comprising a pharmaceutically acceptable salt of a N-dithiocarboxyamino acid and a pharmaceutically acceptable carrier. The pharmaceutically acceptable salts may be the alkali or alkaline earth metal salts of N-dithiocarboxy-taurine, N-dithiocarboxy-aspartic acid, N-dithiocarboxy-methionine, N-dithiocarboxy-glycine, N-dithiocarboxy-asparagine, N,N1-bis(dithiocarboxy) lysine and N,N1-bis(dithiocarboxy)-ornithine. The composition may additionally contain other active ingredients e.g. methionine, aspartic acid, 2, 3-di-mercapto-1-propanol and choline.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP77963 | 1963-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1042531A true GB1042531A (en) | 1966-09-14 |
Family
ID=11483172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB924/64A Expired GB1042531A (en) | 1963-01-08 | 1964-01-08 | Therapeutic composition |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE1237093B (en) |
FR (1) | FR3120M (en) |
GB (1) | GB1042531A (en) |
-
1964
- 1964-01-04 DE DE1964D0043288 patent/DE1237093B/en active Pending
- 1964-01-07 FR FR959494A patent/FR3120M/en active Active
- 1964-01-08 GB GB924/64A patent/GB1042531A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1237093B (en) | 1967-03-23 |
FR3120M (en) | 1965-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8102804A1 (en) | Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof | |
GB1038678A (en) | Compounds having an adrenocorticotrophic hormone action and process for their manufacture | |
SE7714473L (en) | STORABLE MIXTURE WHICH DISSOLUTES IN WATER PROVIDES A SOLUTION WITH HIGH ANTIMICROBIAL EFFECT | |
GB1397645A (en) | Aza-benzimidazoles | |
GB1142066A (en) | New diphenyl-ureas and process for preparing them | |
ES8506193A1 (en) | Bone-seeking complexes of technetium-99m. | |
GB1042531A (en) | Therapeutic composition | |
ES451256A1 (en) | Stable preparation of water-soluble salts of dehydroepiandrosterone sulfate for parenteral administration | |
ES368955A1 (en) | Procedure for preparing substitute guanidines. (Machine-translation by Google Translate, not legally binding) | |
GB1272606A (en) | Imidazolinyl benzalhydrazone and a process for its preparation | |
ES351689A1 (en) | Improvements in or relating to Compositions Containing Choline Chloride | |
JPS56125313A (en) | Remedy for damage | |
JPS5294414A (en) | Production of stable solid composition or complex containing salicylic acid choline * solid dosage form containing same as effective component and use of same | |
GB993125A (en) | Novel pharmaceutical compositions for the treatment of fatigue | |
GB1114944A (en) | Stilbene-azo and stilbene-azoxy dyes and their preparation | |
GB1180252A (en) | Stimulant Composition for Administration to Animals | |
GB715976A (en) | Improvements in medical preparations for removing toxic heavy metals from the human body | |
GB1448295A (en) | Thiosemicarbazones | |
ES8602395A1 (en) | Concentrated aqueous surfactant. | |
GB818248A (en) | Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability | |
SE7613849L (en) | FOR INJECTION COMPLETED SOLUTIONS | |
GB692968A (en) | Process for the manufacture of stable preparations of vitamins of the b group | |
ES458413A1 (en) | Pharmaceutical composition | |
FR2081583A1 (en) | Threonine proto-glutamate - as hepatoprotective agent | |
GB1199758A (en) | Arylsulphonyl-Semicarbazides and their production |